References
<A NAME="RU21804ST-1A">1a</A>
Kuyama H.
Nukada T.
Ito Y.
Nakahara Y.
Ogawa T.
Carbohydr. Res.
1995,
268:
C1
<A NAME="RU21804ST-1B">1b</A>
Takahashi Y.
Ogawa T.
Carbohydr. Res.
1987,
164:
277
<A NAME="RU21804ST-2">2</A>
Irie T.
Uekama K.
J. Pharm. Sci.
1997,
86:
147
<A NAME="RU21804ST-3">3</A>
Kobayashi S.
Kainuma K.
Franch D. In Proc. 1st Int. Symp. on Cyclodextrins (Budapest, 1981)
Szejtli J.
D. Reidel;
Dordrecht:
1982.
p.51
<A NAME="RU21804ST-4">4</A>
Kobayashi S.
Maruyam K.
Kainuma K.
J. Jpn. Soc. Starch Sci.
1983,
30:
231
<A NAME="RU21804ST-5">5</A>
Koizumi K.
Okada Y.
Kubota Y.
Utamura T.
Chem. Pharm. Bull.
1987,
35:
3413
<A NAME="RU21804ST-6">6</A>
Okada Y.
Kuboda Y.
Koizumi K.
Hizukuri S.
Ohfuji T.
Ogata K.
Chem. Pharm. Bull.
1986,
36:
2176
<A NAME="RU21804ST-7">7</A>
Yamamoto Y.
Kubota Y.
Inoue Y.
Chûjo R.
Kobayashi S.
Chem. Lett.
1988,
495
<A NAME="RU21804ST-8">8</A>
Ning J.
Zhang W.
Yi Y.
Yang G.
Wu Z.
Yi J.
Kong F.
Bioorg. Med. Chem.
2003,
11:
2193
<A NAME="RU21804ST-9">9</A>
Yan J.
Zong H.
Shen A.
Chen S.
Yin X.
Shen X.
Liu W.
Gu X.
Gu J.
Int. Immunopharmacol.
2003,
3:
1861
<A NAME="RU21804ST-10">10</A>
Wu Z.
Ning J.
Kong F.
Carbohydr. Res.
2003,
338:
2203
<A NAME="RU21804ST-11">11</A>
Cyclization Procedure: Compound 3 (400 mg, 0.115 mmol) or 8 (400 mg, 0.087 mmol) was dried under high vacuum for 2 h, then dissolved in anhyd
CH2Cl2 (15 mL). TMSOTf (5 µL) was added dropwise at -20 °C under N2 protection. The reaction mixture was stirred for 3 h, during which time the temperature
was gradually raised to ambient temperature. Then the mixture was neutralized with
Et3N. Concentration of the reaction mixture, followed by purification on a silica gel
column with 2:1 petroleum ether-EtOAc as the eluent gave 4 (154 mg, 40.1%) or 9 (125 mg, 32.4%).
<A NAME="RU21804ST-12A">12a</A>
Zeng Y.
Ning J.
Kong F.
Tetrahedron Lett.
2002,
43:
3729
<A NAME="RU21804ST-12B">12b</A>
Zeng Y.
Ning J.
Kong F.
Carbohydr. Res.
2003,
338:
307
<A NAME="RU21804ST-13">13</A>
All the new compounds involved in the study were identified by 1H NMR and/or 13C NMR spectrometry, and elemental analyses. Selected data for some important compounds:
Compound 3: [α]D +46.3 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 8.41 (s, 1 H, C=NH), 6.31 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.97 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.92 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.88 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.85 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.79 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.61 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.56 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.50 (d, 1 H, J
1,2 = 7.9 Hz, H-1). 13C NMR (100 MHz, CDCl3): δ = 101.5, 101.4, 100.7, 100.3, 100.0, 99.8 (6 β-C-1), 94.2, 93.9, 92.8 (3 α-C-1).
Anal. Calcd for C170H170Cl3NO73: C, 58.46; H, 4.87. Found: C, 58.72; H, 4.99.
Compound 4: [α]D +48.6 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 5.01 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.93 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.90 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.80 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.77 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.70 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.55 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.50 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.46 (d, 1 H, J
1,2 = 7.9 Hz, H-1). 13C NMR (100 MHz, CDCl3): δ = 102.0, 101.5, 101.4, 100.4, 100.4, 100.2 (6 β-C-1), 94.0, 92.1, 89.9 (3 α-C-1).
MALDI-TOF MS: Calcd for C168H168O72: 3339.1 [M]. Found: 3363 [M + Na].
Compound 5: [a]D +16.7 (c 1.0, H2O). 1H NMR (400 MHz, CDCl3): d = 5.39 (d, 3 H, J = 3.8 Hz, 3 H-1), 4.55 (d, 6 H, J = 7.9 Hz, 6 H-1), 4.30-4.20 (m, 4 H), 4.02-3.97 (m, 12 H), 3.86-3.70 (m, 20 H), 3.59-3.50
(m, 11 H), 3.45-3.33 (m, 7 H). 13C NMR (100 MHz, D2O): d = 102.8 (6 C-1 for b bonds, J
C-H = 163.3 Hz), 99.1 (3 C-1 for a bond, J
C-H = 171.6 Hz), 85.1, 84.4, 76.4, 76.0, 75.9, 75.6, 73.4, 73.2, 73.1, 72.2, 71.5, 71.2,
71.0, 70.8, 70.3, 69.9, 69.6, 69.0, 68.8, 68.4, 67.7 (C-2,3,4,5,6, some signals were
overlapped). MALDI-TOF MS: Calcd for C54H90O45: 1459.3 [M]. Found: 1482.6 [M + Na].
Compound 8: [a]D +37.5 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): d = 8.40 (s, 1 H, C=NH), 6.30 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.96 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.93 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.90 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.85 (d, 2 H, J
1,2 = 3.6 Hz, 2 H-1), 4.80 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.65 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.62 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.54 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.44 (d, 1 H, J
1,2 = 7.9 Hz, H-1). 13C NMR (100 MHz, CDCl3): d = 101.8, 101.6, 101.5, 100.9, 100.5, 100.3, 100.1, 99.8 (8 b-C-1), 94.5, 94.1,
93.6, 92.7 (4 a-C-1). Anal. Calcd for C226H226Cl3NO97: C, 58.82; H, 4.90. Found: C, 60.07; H, 4.94.
Compound 9: [a]D +42.8 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3): d = 4.98 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.96 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.90 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.86 (d, 2 H, J
1,2 = 3.6 Hz, 2 H-1), 4.81 (d, 1 H, J
1,2 = 3.6 Hz, H-1), 4.76 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.66 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.62 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.53 (d, 1 H, J
1,2 = 7.9 Hz, H-1), 4.45 (d, 1 H, J
1,2 = 7.9 Hz, H-1). 13C NMR (100 MHz, CDCl3): d = 102.3, 101.7, 101.5, 101.5, 100.8, 100.5, 100.3, 99.9 (8 b-C-1), 94.7, 94.3,
93.7, 90.0 (4 a-C-1). MALDI-TOF MS: Calcd for C224H224O96: 4452 [M]. Found: 4475 [M + Na].
Compound 10: [a]D +24.1 (c 1.0, H2O). 1H NMR (400 MHz, CDCl3): d = 5.24 (d, 4 H, J = 3.6 Hz, 4 H-1), 4.40 (d, 8 H,
J = 8.0 Hz, 8 H-1), 4.13-4.05 (m, 12 H), 3.92-3.80 (m, 22 H), 3.70-3.54 (m, 26 H),
3.42-3.32 (m, 12 H). 13C NMR (100 MHz, D2O): d = 102.8 (8 C-1 for b bonds, J
C-H = 164.3 Hz), 99.1 (4 C-1 for a bond, J
C-H = 173.1 Hz), 82.6, 81.9, 75.9, 75.6, 73.5, 73.2, 73.0, 72.8, 72.5, 72.4, 72.2, 71.8,
71.2, 70.8, 69.9, 69.6, 68.4, 67.7, 60.8, 60.5 (C-2,3,4,5,6, some signals were overlapped).
MALDI-TOF MS: Calcd for C72H120O60: 1945.7 [M]. Found: 1969.0 [M + Na].